Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain

NCT00565760 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Moderate to Severe Pain

Interventions

DRUG: Q8003
DRUG: Placebo

Sponsor

QRxPharma Inc.